Papers: 10.1371/journal.pone.0241697

https://doi.org/10.1371/journal.pone.0241697

Implantable cardioverter defibrillator therapy is cost effective for primary prevention patients in Taiwan: An analysis from the Improve SCA trial

Cited by: 6
Author(s): Reece Holbrook, Lucas Higuera, Kael Wherry, Dave Phay, Yu‐Cheng Hsieh, Kuo‐Hung Lin, Yen‐Bin Liu
Published: almost 6 years ago

Software Mentions 1